Global Dry Eye Disease Market Research Report 2019

Table of Contents

Executive Summary

1 Dry Eye Disease Market Overview

• 1.1 Product Overview and Scope of Dry Eye Disease
• 1.2 Dry Eye Disease Segment by Type
  • 1.2.1 Global Dry Eye Disease Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Artificial Tears
  • 1.2.3 Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
  • 1.2.4 Punctal Plugs
  • 1.2.5 Secretagogue
• 1.3 Dry Eye Disease Segment by Application
  • 1.3.1 Dry Eye Disease Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Independent Pharmacies & Drug Stores
  • 1.3.4 Online pharmacies
• 1.4 Global Dry Eye Disease Market by Region
  • 1.4.1 Global Dry Eye Disease Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Dry Eye Disease Market Size
  • 1.5.1 Global Dry Eye Disease Revenue (2014-2025)
  • 1.5.2 Global Dry Eye Disease Production (2014-2025)

2 Global Dry Eye Disease Market Competition by Manufacturers

• 2.1 Global Dry Eye Disease Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Dry Eye Disease Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Dry Eye Disease Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Dry Eye Disease Production Sites, Area Served, Product Types
• 2.5 Dry Eye Disease Market Competitive Situation and Trends
  • 2.5.1 Dry Eye Disease Market Concentration Rate
  • 2.5.2 Dry Eye Disease Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Dry Eye Disease Production Market Share by Regions

• 3.1 Global Dry Eye Disease Production Market Share by Regions
• 3.2 Global Dry Eye Disease Revenue Market Share by Regions (2014-2019)
• 3.3 Global Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Dry Eye Disease Production
  • 3.4.1 North America Dry Eye Disease Production Growth Rate (2014-2019)
  • 3.4.2 North America Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Dry Eye Disease Production
  • 3.5.1 Europe Dry Eye Disease Production Growth Rate (2014-2019)
  • 3.5.2 Europe Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Dry Eye Disease Production (2014-2019)
  • 3.6.1 China Dry Eye Disease Production Growth Rate (2014-2019)
  • 3.6.2 China Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Dry Eye Disease Production (2014-2019)
  • 3.7.1 Japan Dry Eye Disease Production Growth Rate (2014-2019)
  • 3.7.2 Japan Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Dry Eye Disease Consumption by Regions

• 4.1 Global Dry Eye Disease Consumption by Regions
• 4.2 North America Dry Eye Disease Consumption (2014-2019)
• 4.3 Europe Dry Eye Disease Consumption (2014-2019)
• 4.4 China Dry Eye Disease Consumption (2014-2019)
• 4.5 Japan Dry Eye Disease Consumption (2014-2019)

5 Global Dry Eye Disease Production, Revenue, Price Trend by Type

• 5.1 Global Dry Eye Disease Production Market Share by Type (2014-2019)
• 5.2 Global Dry Eye Disease Revenue Market Share by Type (2014-2019)
• 5.3 Global Dry Eye Disease Price by Type (2014-2019)
• 5.4 Global Dry Eye Disease Production Growth by Type (2014-2019)

6 Global Dry Eye Disease Market Analysis by Applications

• 6.1 Global Dry Eye Disease Consumption Market Share by Application (2014-2019)
• 6.2 Global Dry Eye Disease Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Dry Eye Disease Business

• 7.1 Santen
  • 7.1.1 Santen Dry Eye Disease Production Sites and Area Served
  • 7.1.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.1.3 Santen Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Novartis
  • 7.2.1 Novartis Dry Eye Disease Production Sites and Area Served
  • 7.2.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.2.3 Novartis Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 llergan
  • 7.3.1 llergan Dry Eye Disease Production Sites and Area Served
  • 7.3.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.3.3 llergan Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Shire
  • 7.4.1 Shire Dry Eye Disease Production Sites and Area Served
  • 7.4.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.4.3 Shire Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 TRB Chemedica
  • 7.5.1 TRB Chemedica Dry Eye Disease Production Sites and Area Served
  • 7.5.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.5.3 TRB Chemedica Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Sun Pharmaceutical
  • 7.6.1 Sun Pharmaceutical Dry Eye Disease Production Sites and Area Served
  • 7.6.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.6.3 Sun Pharmaceutical Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Senju
  • 7.7.1 Senju Dry Eye Disease Production Sites and Area Served
  • 7.7.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.7.3 Senju Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Sentiss Pharma
  • 7.8.1 Sentiss Pharma Dry Eye Disease Production Sites and Area Served
  • 7.8.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.8.3 Sentiss Pharma Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Johnson & Johnson
  • 7.9.1 Johnson & Johnson Dry Eye Disease Production Sites and Area Served
  • 7.9.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.9.3 Johnson & Johnson Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Otsuka
  • 7.10.1 Otsuka Dry Eye Disease Production Sites and Area Served
  • 7.10.2 Dry Eye Disease Product Introduction, Application and Specification
  • 7.10.3 Otsuka Dry Eye Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Mitotech
• 7.12 FCI

8 Dry Eye Disease Manufacturing Cost Analysis

• 8.1 Dry Eye Disease Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Dry Eye Disease
• 8.4 Dry Eye Disease Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Dry Eye Disease Distributors List
• 9.3 Dry Eye Disease Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Dry Eye Disease Market Forecast

• 11.1 Global Dry Eye Disease Production, Revenue Forecast
  • 11.1.1 Global Dry Eye Disease Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Dry Eye Disease Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Dry Eye Disease Price and Trend Forecast (2019-2025)
• 11.2 Global Dry Eye Disease Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Dry Eye Disease Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Dry Eye Disease Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Dry Eye Disease Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Dry Eye Disease Production, Revenue Forecast (2019-2025)
• 11.3 Global Dry Eye Disease Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Dry Eye Disease Consumption Forecast (2019-2025)
  • 11.3.2 Europe Dry Eye Disease Consumption Forecast (2019-2025)
  • 11.3.3 China Dry Eye Disease Consumption Forecast (2019-2025)
  • 11.3.4 Japan Dry Eye Disease Consumption Forecast (2019-2025)
• 11.4 Global Dry Eye Disease Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Dry Eye Disease Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List